Mometasone Furoate Market Size

  • Report ID: 5507
  • Published Date: May 07, 2024
  • Report Format: PDF, PPT

Mometasone Furoate Market Size

Mometasone Furoate Market size is poised to reach USD 3 billion by the end of 2036, growing at a CAGR of 7% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of mometasone furoate was valued at USD 1 Billion. The market is booming as a result of the rising uncontrolled asthmatic conditions, which affect both children and adults. According to a report by CDC, about 44% of children, and 60% of adults have uncontrolled asthma.

Additionally, there is a rising awareness and focus on skincare and overall well-being as people become more conscious of taking care of their skin and seeking professional advice when needed. This has surpassed the demand for dermatological treatments like mometasone. Also, the expansion of the aging population worldwide is contributing to the growth of the sector.


Mometasone Furoate Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Rajrani Baghel


  • Report ID: 5507
  • Published Date: May 07, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2023, the industry size of the mometasone furoate market was over USD 1 billion.

The market size for the mometasone furoate market is projected to cross USD 3 billion by the end of 2036 expanding at a CAGR of 7% during the forecast period i.e., between 2024 and 2036.

The major players in the market are Bausch Health Companies Inc., Glenmark Pharmaceuticals Limited, Vetoquinol USA, AstraZeneca plc, Intersect ENT, Hikma Pharmaceuticals, Medlab Pharmaceuticals Private Limited, AdvaCare Pharma, Dermocare Laboratories, Taro Pharmaceutical Industries Ltd., Kyorin Remedio Co., Ltd, Teikoku Seiyaku Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceuticals., and others.

In terms of route of administration, the topical segment is anticipated to account for the largest market share of 42% during 2024-2036.

The North American mometasone furoate market is poised to hold the highest share of 47% by 2036.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample